They are discussed for different reasons, have different research histories, and raise different safety questions
Here is who they are, and what each has at stake
(2024) Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study Wallace, Ian R, et al (2012) Sex hormone binding globulin and insulin resistance Bhasin S, Lincoff AM, Nissen SE, et al
BPC also upregulates growth hormone receptors on all the cells
Also, like CJC-1295, BPC-157 presents a risk of immunogenicity
As interest in muscle recovery research grows across sports science and regenerative medicine fields, BPC-157 continues to surface in peer-reviewed literature exploring how the bodys repair mechanisms might be modeled and better understood